SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

NERVGEN PHARMA CORP - Q3 NET LOSS WAS C$6.4 MLN, OR C$0.06 PER SHARE

NGEN

Related stories